Clinical trial
Urinary DENND1A.V2 as a Predictor of Pubertal Hyperandrogenemia
NCT02611128 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Urinary DENND1A.V2 as a Predictor of Pubertal Hyperandrogenemia
- Lead sponsor
- University of Virginia
- Phase
- Observational
- Overall status
- Suspended
- Start date
- May 29, 2015
- Completion date
- December 31, 2024
- Enrollment
- 65 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hyperandrogenism, polycystic ovary syndrome, puberty